Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Bio Medica Laboratories Limited (NSE: BMLL), ISIN INE1BKA01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
BMLL last traded at ₹163.70 (+9.13%), with a 52-week range of ₹101.50 to ₹181.00 (as of 13 Oct 2026).
Shareholding as of Jun 2026: promoters 67.70%, FIIs 0.29%, DIIs 2.31%, mutual funds 0.00%.
EquiSense Score (ECS): 66/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.